Marc De Braekeleer
- Hematology top 1%
- Acute Myeloid Leukemia Research 43
- Chronic Myeloid Leukemia Treatments 27
- Reproductive Medicine top 1%
- Sperm and Testicular Function 22
- Genetics top 1%
- Genomic variations and chromosomal abnormalities 34
- Genetics top 1%
- Genomic variations and chromosomal abnormalities 34
-
- Prenatal Screening and Diagnostics 23
-
- Cystic Fibrosis Research Advances 36
-
- Chromosomal and Genetic Variations 23
-
- Acute Lymphoblastic Leukemia research 22
Marc De Braekeleer
233 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 133
- Hematology 975
- Reproductive Medicine 719
- Genetics 1.7k
- Genetics 634
- Pediatrics, Perinatology and Child Health 986
Countries citing papers authored by Marc De Braekeleer
This map shows the geographic impact of Marc De Braekeleer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc De Braekeleer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc De Braekeleer more than expected).
Fields of papers citing papers by Marc De Braekeleer
This network shows the impact of papers produced by Marc De Braekeleer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc De Braekeleer. The network helps show where Marc De Braekeleer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc De Braekeleer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 62 | |
| 2 | 2015 | 61 | |
| 3 | 2015 | 18 | |
| 4 | 2014 | 2 | |
| 5 | 2014 | 75 | |
| 6 | 2012 | 4 | |
| 7 | 2011 | 66 | |
| 8 | 2011 | 10 | |
| 9 | 2011 | 22 | |
| 10 | 2010 | 2 | |
| 11 | 2009 | 18 | |
| 12 | 2007 | 19 | |
| 13 | 2006 | 10 | |
| 14 | 2004 | 12 | |
| 15 | False-positive captopril renography in patients taking calcium antagonists. | 1998 | 12 |
| 16 | 1991 | 1 | |
| 17 | More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians. | 1990 | 45 |
| 18 | Homogénéité ou diversité? L'histoire de la population du Québecrevue à travers ses gènes | 1990 | 10 |
| 19 | 1989 | 7 | |
| 20 | 1986 | 1 |
About Marc De Braekeleer
Marc De Braekeleer is a scholar working on Hematology, Genetics and Reproductive Medicine, having authored 235 papers that have together received 5.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (43 papers), Cystic Fibrosis Research Advances (36 papers), Genomic variations and chromosomal abnormalities (34 papers), Chronic Myeloid Leukemia Treatments (27 papers), Prenatal Screening and Diagnostics (23 papers), Chromosomal and Genetic Variations (23 papers), Sperm and Testicular Function (22 papers) and Acute Lymphoblastic Leukemia research (22 papers). The work is most often cited by research in Hematology (975 citations), Reproductive Medicine (719 citations) and Genetics (1.7k citations). Marc De Braekeleer has collaborated with scholars based in France, Canada and Germany. Frequent co-authors include Fréderic Morel, T.-N. Dao, Nathalie Douet‐Guilbert, Marie‐Josée Le Bris, Claude Férec, Étienne De Braekeleer, Jean Mathieu, Aurore Perrin, V. Amice and Jonathan R. LaRochelle. Their work appears in journals such as The Lancet, Blood and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.